Laurion Capital Management LP Astrazeneca PLC Transaction History

Laurion Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $5.2 Million - $6.29 Million	77,879 New	77,879 $6.07 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $16 Million - $41 Million	301,760 Added 856.66%	336,985 $18.5 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $2.09 Million - $2.51 Million	35,225 New	35,225 $2.33 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $648,240 - $765,960	-12,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $666,720 - $729,480	12,000 New	12,000 $721,000
Q3 2019 Nov 13, 2019	SELL	$40.12 - $45.47 $292,876 - $331,931	-7,300 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$37.28 - $41.68 $272,144 - $304,264	7,300 New	7,300 $301,000
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $210,102 - $236,493	-5,700 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$34.76 - $39.72 $198,132 - $226,404	5,700 New	5,700 $226,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.